Reuters - Johnson & Johnson said on Thursday it will pay $158 million to settle a Texas lawsuit accusing the drugmaker of improperly marketing its Risperdal anti-psychotic drug to state residents on the Medicaid health program for the poor.
You are here:
Health 
Diseases & Conditions J&J to pay $158 million to settle Texas Risperdal case
(Reuters)
Diseases & Conditions J&J to pay $158 million to settle Texas Risperdal case
(Reuters)
